Having survived a three-year global money-laundering greylist censure that had impacted Botswana’s investment charm from 2018 ...

The seat is part of the Financial Action Task Force’s (FATF) inaugural guest initiative that allows countries from the watchdog’s regional bodies to participate in key meetings and engage directly in ...

South Africa underwent a mutual evaluation (peer review) of its AML/CFT system by the FATF between April 2019 and June 2021 ... to establish a regulatory framework to protect nonprofit organisations ...

Since the FATF Mutual Evaluation of South Africa in October 2021 ... Supervision is critical to ensuring that a cohesive and resilient AML/CFT/CPF framework exists within South Africa. All AML/CFT/CPF ...

The Treasury warns that without regulation, the use of virtual assets poses risks such as money laundering, terrorism ...

Imagine a world where sending money is as easy as texting your friend – no banks, no borders, just instantaneous.

Malaysia, she added, aims to enhance its legal framework to combat financial ... as Malaysia prepares for its next Mutual Evaluation by the FATF in 2025, a process that assesses the nation ...

“Participating in the FATF Assessor Training was an invaluable experience that significantly enhanced my understanding of the mutual evaluation process and FATF Standards,” said Mr Adamberry. “The ...

The Department of Social Development has issued 41,787 notices of non-compliance to non-profit organisations (NPOs), with a ...

The Committee of Experts on the Evaluation of Anti-Money Laundering Measures and the ... Through a dynamic process of mutual evaluations, peer review and regular follow-up of its reports, MONEYVAL ...

As with any for-profit business enterprise, the mutual fund industry charges fees for the services it offers. Actively managed fund services consist of managing a pool of commingled assets with an ...

The UK medicines regulator has launched its mutual recognition framework for authorising medicines in a move that it says will help to bring new drugs to patients in the UK more quickly.